January 19th 2021, 10:00pm
In the final analysis of the phase 2 TASCO1 trial, patients within the Lonsurf and Avastin arm reached a median overall survival of 22.31 months compared with 17.67 months in the Xeloda and Avastin arm.
January 17th 2021, 3:00pm
The researchers concluded that the overall low health-related quality of life scores for young CRC survivors in the categories of social and functional well-being should be targeted by appropriate methods, which could include counseling and quality of life interventions.
December 28th 2020, 4:00pm
National guidelines recommend initial surveillance colonoscopy one year after colorectal cancer surgery, but only 57.5% of patients received one in this study due to racial disparities.
December 23rd 2020, 9:32pm
As we enter the holiday season, we know that quality time spent connecting with family is upon us. Even if your gatherings are virtual this year, we encourage you to bring up your family medical history and support each other in understanding your family’s risk factors for colorectal cancer.
December 23rd 2020, 8:30pm
December 22nd 2020, 6:00pm
For one cancer survivor, laughter might have been the best medicine.
December 22nd 2020, 5:00am
December 17th 2020, 12:00am
Watch our metastatic colorectal cancer webinar where an expert panel discussed topics highly relevant to nurses as they care for patients and provide support to caregivers.
December 11th 2020, 4:30pm
From actor Jason Momoa gifting a trident to a young fan of the superhero movie “Aquaman” who is receiving treatment for an aggressive form of brain cancer, to data demonstrating the regular consumption of chili peppers is associated with lower cancer mortality rates, here’s everything happening in the cancer landscape this week.
December 5th 2020, 12:00am
Watch our first colorectal cancer webinar where an expert panel discussed topics highly relevant to patients, caregivers and advocates.
7 Recent Cancer-Related Quality of Life Updates Patients May Have Missed
5 Recent COVID-19 News and Updates That Patients With Cancer May Have Missed
FDA Approves Cabometyx-Opdivo For Metastatic RCC Treatment
Novel Therapy Granted Priority Review By FDA for Treatment of Anal Cancer Subset
